GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (NAS:OPT) » Definitions » Other Long Term Assets

OPT (Opthea) Other Long Term Assets : $1.60 Mil (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Opthea Other Long Term Assets?

Opthea's other long-term assets for the quarter that ended in Dec. 2024 was $1.60 Mil.

Opthea's quarterly other long-term assets increased from Dec. 2023 ($0.01 Mil) to Jun. 2024 ($0.47 Mil) and increased from Jun. 2024 ($0.47 Mil) to Dec. 2024 ($1.60 Mil).

Opthea's annual other long-term assets declined from Jun. 2022 ($0.11 Mil) to Jun. 2023 ($0.05 Mil) but then increased from Jun. 2023 ($0.05 Mil) to Jun. 2024 ($0.47 Mil).

Opthea Other Long Term Assets Historical Data

The historical data trend for Opthea's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea Other Long Term Assets Chart

Opthea Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.17 0.11 0.05 0.47

Opthea Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.05 0.01 0.47 1.60

Opthea Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Opthea Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (NAS:OPT) » Definitions » Other Long Term Assets
Comparable Companies
ASX:CU6 ASX:PYC ASX:BOT ASX:CUV ASX:IMM ASX:OCC ASX:IMU ASX:DXB ASX:RAC ASX:PAR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
UKJ:Germany OPT:Australia
Address
650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141
Website
https://www.opthea.com
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.